MOJO RISEN — Class I drug recall D-1614-2014
Terminated recall by Eugene Oregon, Inc., reported 2014-10-08, distributed in FL, IL, IN, LA, MD, ME, NJ, PA…. Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared silde
| Recall number | D-1614-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eugene Oregon, Inc., Levittown, PA, United States |
| Recall initiated | 2014-05-05 |
| Classified | 2014-09-29 |
| Reported by FDA | 2014-10-08 |
| Terminated | 2015-04-01 |
| Distributed | FL, IL, IN, LA, MD, ME, NJ, PA, SC, TX, WA |
| Quantity | 57 boxes |
| Reason classes | undeclared allergen, unapproved product |
Product
MOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Springville, UT 84663
Reason for recall
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1614-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.